Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function
about
A reporter mouse for optical imaging of inflammation in mdx musclesEffect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.The immune system in Duchenne muscular dystrophy: Friend or foe.Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotypeChemotaxis and Immunoregulatory Function of Cardiac γδ T Cells in Dystrophin-Deficient Mice.Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophyMacrophage Depletion Impairs Skeletal Muscle Regeneration: the Roles of Pro-fibrotic Factors, Inflammation, and Oxidative Stress.Identification and analysis of a key long non-coding RNAs (lncRNAs)-associated module reveal functional lncRNAs in cardiac hypertrophy.Densification of Type I Collagen Matrices as a Model for Cardiac Fibrosis.Effect of Ibuprofen on Skeletal Muscle of Dysferlin-null Mice.TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding.Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations.Reduced Appendicular Lean Body Mass, Muscle Strength, and Size of Type II Muscle Fibers in Patients with Spondyloarthritis versus Healthy Controls: A Cross-Sectional Study.Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
P2860
Q35576368-9CF6B0C5-4FA4-46B9-B872-AF5DBE47CA6FQ36026239-90A9DE56-FD92-4AC0-BD17-6A8572A9F8DBQ36105761-527C0FFE-8263-4F23-A365-666E164ACDAAQ36422465-CB8A16DC-7A18-4D7C-A231-763818AE9CCFQ37374329-EB9CD5F5-7219-48CA-9A77-2F42012671C1Q39318972-97A6B33F-A3F4-4E51-B56E-26BF872FB3F9Q39342422-2E321AD2-5B35-411B-94BF-06A459D356F3Q39410461-88C5C698-00A1-47E4-BE0C-CF45216287F5Q39412400-57D168AA-863F-4224-8D5D-B38F83F3B0D5Q47333052-0A5E2CF4-8C64-4FB0-B844-DF98DA935445Q47704324-7FA5B621-993A-4446-ACEE-FD65B11BC89EQ50128178-0F7F8BD5-8B83-4E7F-A22C-015E7F64FC1EQ50233826-F026EEE8-1D05-4F42-8F08-BC69FDEB51C7Q51243987-8AD343B3-7588-4A84-B53A-5396BD41EB7AQ53021234-EC44DB78-3B89-4395-87BB-9C5ED5855E73Q54116477-B9D2A99D-9294-4A15-B11F-8093738BB87D
P2860
Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-term administration of th ...... ively impacts cardiac function
@ast
Long-term administration of th ...... ively impacts cardiac function
@en
Long-term administration of th ...... ively impacts cardiac function
@nl
type
label
Long-term administration of th ...... ively impacts cardiac function
@ast
Long-term administration of th ...... ively impacts cardiac function
@en
Long-term administration of th ...... ively impacts cardiac function
@nl
prefLabel
Long-term administration of th ...... ively impacts cardiac function
@ast
Long-term administration of th ...... ively impacts cardiac function
@en
Long-term administration of th ...... ively impacts cardiac function
@nl
P2093
P2860
P1476
Long-term administration of th ...... ively impacts cardiac function
@en
P2093
H L Sweeney
L Martinez
M C Jordan
M J Spencer
N V Ermolova
S A Vetrone
P2860
P304
P356
10.1016/J.NMD.2014.04.006
P577
2014-04-26T00:00:00Z